Outcomes based on Albumin-Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
| Image |  |
|---|---|
| Description | scientific article published on 01 July 2019 |
| Author/s |
author: Ryan Ward Kelley |
| Publication date | July 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |